Research Group
Cancer Biomarkers
Sponsor
University of Miami
Status
Recruiting
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT04240327
The purpose of this research study is to determine if the interpretation of multiparametric MRI (mpMRI) with an algorithm called habitat risk score (HRS) in combination with a panel of blood and urine biomarkers is more effective at detecting prostate cancer than standard of care interpretation of mpMRI with the Prostate Imaging Reporting and Data System (PIRADS).
Condition
PSA, Elevated PSA, Prostate Cancer
Investigators
Sanoj Punnen, MD, MAS, Elena M Cortizas, MS